{"text_format":"1","workbook":"xlsx","n_sheets":5,"sheets":["Inputs","Instructions","Your Impact Results","Definitions","Confidentiality and data use"],"not_rendered":{"charts":0,"images":1,"macros":1,"external_links":0,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Inputs","index":0,"n_rows":244,"n_cols":36,"rows_kept":244,"cut":false,"hidden":true,"merged":[]}
["Investment features",null,null,null,null,"WHO",null,null,null,null,"WHAT",null,null,null,"RISK",null,null,"CONTRIBUTION",null,null,null,"KPI1",null,null,"KPI 2",null,null,null,"KPI 4",null,null,null,"KPI 6",null,null,"All KPIs"]
["Primary Region",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"We cannot report on this KPI"]
["East Asia",null,null,null,null,"Geography of investment",null,null,null,null,"Service/product type",null,null,null,"Quality assurance mechanisms",null,null,"Mechanisms used to engage target stakeholders",null,null,null,null,null,null,null,null,null,null,"Type of training",null,null,null,null,null,null,"This KPI is not relevant to this investee’s business model"]
["Eastern Europe, Russia, & Central Asia",null,null,null,null,"Urban",null,null,null,null,"Preventative",null,null,null,"Certifications",null,null,"Our investees engage directly with stakeholders, but we do not ",null,null,null,null,null,null,null,null,null,null,"Anti-harassment training",null,null,null,null,null,null,"We do not have the data"]
["Latin America & Caribbean (including Mexico)",null,null,null,null,"Peri-urban",null,null,null,null,"Diagnostic",null,null,null,"Confidential complaint system for patients, employees, or others",null,null,"We collect impact data from stakeholders via interviews and/or surveys",null,null,null,null,null,null,null,null,null,null,"Enterprise or business development training",null,null,null,null,null,null,"We cannot share the data due to confidentiality and/or legal concerns"]
["Middle East & North Africa",null,null,null,null,"Rural",null,null,null,null,"Treatment",null,null,null,"Coordination of services with community leaders and community health care organizations",null,null,"We identify stakeholder need(s) in consultation with stakeholders ",null,null,null,null,null,null,null,null,null,null,"General social and environmental performance training",null,null,null,null,null,null,"Other"]
["Oceania",null,null,null,null,null,null,null,null,null,"Palliative",null,null,null,"Disposal of all waste and hazardous materials in a safe and environmentally responsible manner",null,null,"We monitor stakeholder satisfaction",null,null,null,null,null,null,null,null,null,null,"Racial equity training"]
["South Asia",null,null,null,null,null,null,null,null,null,null,null,null,null,"Informing persons enrolled in clinical research of the risks and benefits, and of their right to drop out without risk of reprisal",null,null,"None of these mechanisms were used",null,null,null,null,null,null,null,null,null,null,"Vocational or technical training"]
["Southeast Asia",null,null,null,null,"Target stakeholder demographic",null,null,null,null,"Stage of value chain",null,null,null,"Policy to never sell or monetize health data without patient consent",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Data Confidence"]
["Sub-Saharan Africa",null,null,null,null,"Women",null,null,null,null,"Research",null,null,null,"Standardized healthcare quality framework",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"High confidence: Data are precise and validated"]
["U.S. & Canada",null,null,null,null,"Children",null,null,null,null,"Production",null,null,null,"Sharing of information of the cost of services offered with patients",null,null,"Mechanisms used to engage investee",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medium confidence: Data rely on some assumptions or extrapolations"]
["Western, Northern, & Southern Europe",null,null,null,null,"Elderly",null,null,null,null,"Procurement and distribution",null,null,null,null,null,null,"Discussion of opportunities to improve financial performance with investees",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Low confidence: Data are heavily reliant on proxies and subjective in nature"]
[null,null,null,null,null,"People with disabilities",null,null,null,null,"Product and service provision",null,null,null,"Certifications and Frameworks",null,null,"Discussion of opportunities to improve impact performance with investees"]
["Stage of business",null,null,null,null,"Populations historically marginalized on the basis of race/ethnicity",null,null,null,null,"Disposal",null,null,null,"Cert: Food and Drug Administration (FDA)",null,null,"Non-financial support and/or technical assistance"]
["Seed/start-up stage",null,null,null,null,"Populations underserved due to geography",null,null,null,null,null,null,null,null,"Cert: European Medicines Agency (EMA)",null,null,"Proxy voting"]
["Venture stage",null,null,null,null,"Low income",null,null,null,null,"Setting",null,null,null,"Cert: Therapeutic Goods Administration (TGA) ",null,null,"Seat on the investee's Board of Directors"]
["Growth stage",null,null,null,null,null,null,null,null,null,"Hospital",null,null,null,"Cert: Medicines and Healthcare Products Regulatory Agency (MHPRA) ",null,null,"Shareholder advocacy"]
["Mature, private companies",null,null,null,null,null,null,null,null,null,"Specialized care facility",null,null,null,"Cert: International Standardisation Organization (ISO) ",null,null,"None of these mechanisms were used"]
["Mature, publicly traded companies",null,null,null,null,null,null,null,null,null,"Community",null,null,null,"Cert: Joint Commission International (JCI) "]
["Not applicable",null,null,null,null,null,null,null,null,null,"Home-based",null,null,null,"Cert: National Committee on Quality Assurance (NCQA) "]
[null,null,null,null,null,null,null,null,null,null,"Virtual",null,null,null,"Cert: European Foundation for Quality Management (EFQM) "]
["Instrument",null,null,null,null,null,null,null,null,null,null,null,null,null,"Cert: Authorities Having Jurisdiction (AHJs) "]
["Deposits & cash equivalents",null,null,null,null,null,null,null,null,null,null,null,null,null,"Cert: Care Quality Commission (CQC) "]
["Private debt",null,null,null,null,null,null,null,null,null,"Healthcare Strategies",null,null,null,"Cert: General Data Protection Regulation (GDPR)"]
["Public debt",null,null,null,null,null,null,null,null,null,"Improving Data for Health Systems Policy and Decision-Making",null,null,null,"Cert: Other"]
["Private equity",null,null,null,null,null,null,null,null,null,"Improving Early Childhood Care and Education",null,null,null,"Framework: Ethical Principles in Health Care (EPiHC)"]
["Public equity",null,null,null,null,"Full list of countries",null,null,null,null,"Improving Energy Alternatives for Healthcare",null,null,null,"Framework: Institute of Medicine (IOM)"]
["Real assets",null,null,null,null,"Afghanistan",null,null,null,null,"Improving Health and Well-Being Across the Workforce",null,null,null,"Framework: Other",null,null,"Mechanisms used to embed impact goals into investment terms"]
["Other (please specify)",null,null,null,null,"Albania",null,null,null,null,"Improving WASH through Water Infrastructure and Management",null,null,null,null,null,null,"Codifying impact targets within our legal documents (e.g., PPMs, investor or shareholder agreements, loan covenants, term sheets)"]
[null,null,null,null,null,"Algeria",null,null,null,null,"Increasing Access to Essential Medicines, Medical Supplies, and Vaccines",null,null,null,null,null,null,"Extending our time horizon expectations in line with our impact goals"]
["Target returns",null,null,null,null,"American Samoa",null,null,null,null,"Increasing Access to Medical Diagnostics and Devices",null,null,null,null,null,null,"Linking investee management team compensation or bonuses to the achievement of impact"]
["Risk-adjusted, market-rate",null,null,null,null,"Andorra",null,null,null,null,"Increasing Consistent Supply of Essential Products and Services",null,null,null,null,null,null,"Providing flexible repayment structures in line with our impact goals"]
["Below-market: closer to market rate",null,null,null,null,"Angola",null,null,null,null,"Reducing Financial Barriers to Health Services",null,null,null,null,null,null,"Reducing the cost of capital in line with our impact goals"]
["Below-market: closer to capital preservation",null,null,null,null,"Antigua and Barbuda",null,null,null,null,null,null,null,null,null,null,null,"None of these mechanisms were used"]
[null,null,null,null,null,"Argentina"]
["General",null,null,null,null,"Armenia"]
["Yes",null,null,null,null,"Aruba",null,null,null,null,"SDGs"]
["No",null,null,null,null,"Australia",null,null,null,null,"1. No poverty"]
[null,null,null,null,null,"Austria",null,null,null,null,"2. Zero hunger"]
[null,null,null,null,null,"Azerbaijan",null,null,null,null,"3. Good health and well-being"]
[null,null,null,null,null,"Bahamas, The",null,null,null,null,"4. Quality education"]
[null,null,null,null,null,"Bahrain",null,null,null,null,"5. Gender equality"]
[null,null,null,null,null,"Bangladesh",null,null,null,null,"6. Clean water and sanitation"]
[null,null,null,null,null,"Barbados",null,null,null,null,"7. Affordable and clean energy"]
[null,null,null,null,null,"Belarus",null,null,null,null,"8. Decent work and economic growth"]
[null,null,null,null,null,"Belgium",null,null,null,null,"9. Industry, innovation, and infrastructure"]
[null,null,null,null,null,"Belize",null,null,null,null,"10. Reduced inequalities"]
[null,null,null,null,null,"Benin",null,null,null,null,"11. Sustainable cities and communities"]
[null,null,null,null,null,"Bermuda",null,null,null,null,"12. Responsible consumption and production"]
[null,null,null,null,null,"Bhutan",null,null,null,null,"13. Climate action"]
[null,null,null,null,null,"Bolivia",null,null,null,null,"14. Life below water"]
[null,null,null,null,null,"Bosnia and Herzegovina",null,null,null,null,"15. Life on land"]
[null,null,null,null,null,"Botswana",null,null,null,null,"16. Peace, justice, and strong institutions"]
[null,null,null,null,null,"Brazil",null,null,null,null,"17. Partnerships for sustainable development"]
[null,null,null,null,null,"British Virgin Islands"]
[null,null,null,null,null,"Brunei Darussalam",null,null,null,null,"Disease/condition addressed"]
[null,null,null,null,null,"Bulgaria",null,null,null,null,"Infectious or parasitic diseases"]
[null,null,null,null,null,"Burkina Faso",null,null,null,null,"Neoplasms (cancers)"]
[null,null,null,null,null,"Burundi",null,null,null,null,"Diseases of the blood"]
[null,null,null,null,null,"Cabo Verde",null,null,null,null,"Diseases of the immune system"]
[null,null,null,null,null,"Cambodia",null,null,null,null,"Endocrine, nutritional, or metabolic diseases"]
[null,null,null,null,null,"Cameroon",null,null,null,null,"Mental, behavioral, or neurodevelopmental disorders"]
[null,null,null,null,null,"Canada",null,null,null,null,"Sleep-wake disorders"]
[null,null,null,null,null,"Cayman Islands",null,null,null,null,"Diseases of the nervous system"]
[null,null,null,null,null,"Central African Republic",null,null,null,null,"Diseases of the visual system"]
[null,null,null,null,null,"Chad",null,null,null,null,"Diseases of the ear"]
[null,null,null,null,null,"Channel Islands",null,null,null,null,"Diseases of the circulatory system"]
[null,null,null,null,null,"Chile",null,null,null,null,"Diseases of the respiratory system"]
[null,null,null,null,null,"China",null,null,null,null,"Diseases of the digestive system"]
[null,null,null,null,null,"Colombia",null,null,null,null,"Diseases of the skin"]
[null,null,null,null,null,"Comoros",null,null,null,null,"Diseases of the musculoskeletal system"]
[null,null,null,null,null,"Congo, Dem. Rep.",null,null,null,null,"Diseases of the genitourinary system"]
[null,null,null,null,null,"Congo, Rep.",null,null,null,null,"Conditions related to sexual health"]
[null,null,null,null,null,"Costa Rica",null,null,null,null,"Pregnancy, childbirth or the peurperium"]
[null,null,null,null,null,"Côte d'Ivoire",null,null,null,null,"Conditions originating in the perinatal period"]
[null,null,null,null,null,"Croatia",null,null,null,null,"Developmental anomalies"]
[null,null,null,null,null,"Cuba",null,null,null,null,"Injury"]
[null,null,null,null,null,"Curaçao"]
[null,null,null,null,null,"Cyprus"]
[null,null,null,null,null,"Czech Republic"]
[null,null,null,null,null,"Denmark"]
[null,null,null,null,null,"Djibouti"]
[null,null,null,null,null,"Dominica"]
[null,null,null,null,null,"Dominican Republic"]
[null,null,null,null,null,"Ecuador"]
[null,null,null,null,null,"Egypt, Arab Rep."]
[null,null,null,null,null,"El Salvador"]
[null,null,null,null,null,"Equatorial Guinea"]
[null,null,null,null,null,"Eritrea"]
[null,null,null,null,null,"Estonia"]
[null,null,null,null,null,"Eswatini"]
[null,null,null,null,null,"Ethiopia"]
[null,null,null,null,null,"Faroe Islands"]
[null,null,null,null,null,"Fiji"]
[null,null,null,null,null,"Finland"]
[null,null,null,null,null,"France"]
[null,null,null,null,null,"French Polynesia"]
[null,null,null,null,null,"Gabon"]
[null,null,null,null,null,"Gambia, The"]
[null,null,null,null,null,"Georgia"]
[null,null,null,null,null,"Germany"]
[null,null,null,null,null,"Ghana"]
[null,null,null,null,null,"Gibraltar"]
[null,null,null,null,null,"Greece"]
[null,null,null,null,null,"Greenland"]
[null,null,null,null,null,"Grenada"]
[null,null,null,null,null,"Guam"]
[null,null,null,null,null,"Guatemala"]
[null,null,null,null,null,"Guinea"]
[null,null,null,null,null,"Guinea-Bissau"]
[null,null,null,null,null,"Guyana"]
[null,null,null,null,null,"Haiti"]
[null,null,null,null,null,"Honduras"]
[null,null,null,null,null,"Hong Kong SAR, China"]
[null,null,null,null,null,"Hungary"]
[null,null,null,null,null,"Iceland"]
[null,null,null,null,null,"India"]
[null,null,null,null,null,"Indonesia"]
[null,null,null,null,null,"Iran, Islamic Rep."]
[null,null,null,null,null,"Iraq"]
[null,null,null,null,null,"Ireland"]
[null,null,null,null,null,"Isle of Man"]
[null,null,null,null,null,"Israel"]
[null,null,null,null,null,"Italy"]
[null,null,null,null,null,"Jamaica"]
[null,null,null,null,null,"Japan"]
[null,null,null,null,null,"Jordan"]
[null,null,null,null,null,"Kazakhstan"]
[null,null,null,null,null,"Kenya"]
[null,null,null,null,null,"Kiribati"]
[null,null,null,null,null,"Korea, Dem. People's Rep."]
[null,null,null,null,null,"Korea, Rep."]
[null,null,null,null,null,"Kuwait"]
[null,null,null,null,null,"Kyrgyz Republic"]
[null,null,null,null,null,"Lao PDR"]
[null,null,null,null,null,"Latvia"]
[null,null,null,null,null,"Lebanon"]
[null,null,null,null,null,"Lesotho"]
[null,null,null,null,null,"Liberia"]
[null,null,null,null,null,"Libya"]
[null,null,null,null,null,"Liechtenstein"]
[null,null,null,null,null,"Lithuania"]
[null,null,null,null,null,"Luxembourg"]
[null,null,null,null,null,"Macao SAR, China"]
[null,null,null,null,null,"Madagascar"]
[null,null,null,null,null,"Malawi"]
[null,null,null,null,null,"Malaysia"]
[null,null,null,null,null,"Maldives"]
[null,null,null,null,null,"Mali"]
[null,null,null,null,null,"Malta"]
[null,null,null,null,null,"Marshall Islands"]
[null,null,null,null,null,"Mauritania"]
[null,null,null,null,null,"Mauritius"]
[null,null,null,null,null,"Mexico"]
[null,null,null,null,null,"Micronesia, Fed. Sts."]
[null,null,null,null,null,"Moldova"]
[null,null,null,null,null,"Monaco"]
[null,null,null,null,null,"Mongolia"]
[null,null,null,null,null,"Montenegro"]
[null,null,null,null,null,"Morocco"]
[null,null,null,null,null,"Mozambique"]
[null,null,null,null,null,"Myanmar"]
[null,null,null,null,null,"Namibia"]
[null,null,null,null,null,"Nauru"]
[null,null,null,null,null,"Nepal"]
[null,null,null,null,null,"Netherlands"]
[null,null,null,null,null,"New Caledonia"]
[null,null,null,null,null,"New Zealand"]
[null,null,null,null,null,"Nicaragua"]
[null,null,null,null,null,"Niger"]
[null,null,null,null,null,"Nigeria"]
[null,null,null,null,null,"North Macedonia"]
[null,null,null,null,null,"Northern Mariana Islands"]
[null,null,null,null,null,"Norway"]
[null,null,null,null,null,"Oman"]
[null,null,null,null,null,"Pakistan"]
[null,null,null,null,null,"Palau"]
[null,null,null,null,null,"Palestine"]
[null,null,null,null,null,"Panama"]
[null,null,null,null,null,"Papua New Guinea"]
[null,null,null,null,null,"Paraguay"]
[null,null,null,null,null,"Peru"]
[null,null,null,null,null,"Philippines"]
[null,null,null,null,null,"Poland"]
[null,null,null,null,null,"Portugal"]
[null,null,null,null,null,"Puerto Rico"]
[null,null,null,null,null,"Qatar"]
[null,null,null,null,null,"Romania"]
[null,null,null,null,null,"Russian Federation"]
[null,null,null,null,null,"Rwanda"]
[null,null,null,null,null,"Samoa"]
[null,null,null,null,null,"San Marino"]
[null,null,null,null,null,"São Tomé and Principe"]
[null,null,null,null,null,"Saudi Arabia"]
[null,null,null,null,null,"Senegal"]
[null,null,null,null,null,"Serbia"]
[null,null,null,null,null,"Seychelles"]
[null,null,null,null,null,"Sierra Leone"]
[null,null,null,null,null,"Singapore"]
[null,null,null,null,null,"Sint Maarten (Dutch part)"]
[null,null,null,null,null,"Slovak Republic"]
[null,null,null,null,null,"Slovenia"]
[null,null,null,null,null,"Solomon Islands"]
[null,null,null,null,null,"Somalia"]
[null,null,null,null,null,"South Africa"]
[null,null,null,null,null,"South Sudan"]
[null,null,null,null,null,"Spain"]
[null,null,null,null,null,"Sri Lanka"]
[null,null,null,null,null,"St. Kitts and Nevis"]
[null,null,null,null,null,"St. Lucia"]
[null,null,null,null,null,"St. Martin (French part)"]
[null,null,null,null,null,"St. Vincent and the Grenadines"]
[null,null,null,null,null,"Sudan"]
[null,null,null,null,null,"Suriname"]
[null,null,null,null,null,"Sweden"]
[null,null,null,null,null,"Switzerland"]
[null,null,null,null,null,"Syrian Arab Republic"]
[null,null,null,null,null,"Taiwan"]
[null,null,null,null,null,"Tajikistan"]
[null,null,null,null,null,"Tanzania"]
[null,null,null,null,null,"Thailand"]
[null,null,null,null,null,"Timor-Leste"]
[null,null,null,null,null,"Togo"]
[null,null,null,null,null,"Tonga"]
[null,null,null,null,null,"Trinidad and Tobago"]
[null,null,null,null,null,"Tunisia"]
[null,null,null,null,null,"Turkey"]
[null,null,null,null,null,"Turkmenistan"]
[null,null,null,null,null,"Turks and Caicos Islands"]
[null,null,null,null,null,"Tuvalu"]
[null,null,null,null,null,"Uganda"]
[null,null,null,null,null,"Ukraine"]
[null,null,null,null,null,"United Arab Emirates"]
[null,null,null,null,null,"United Kingdom"]
[null,null,null,null,null,"United States"]
[null,null,null,null,null,"Uruguay"]
[null,null,null,null,null,"Uzbekistan"]
[null,null,null,null,null,"Vanuatu"]
[null,null,null,null,null,"Venezuela, RB"]
[null,null,null,null,null,"Vietnam"]
[null,null,null,null,null,"Virgin Islands (U.S.)"]
[null,null,null,null,null,"Yemen, Rep."]
[null,null,null,null,null,"Zambia"]
[null,null,null,null,null,"Zimbabwe"]

{"sheet":"Instructions","index":1,"n_rows":21,"n_cols":4,"rows_kept":21,"cut":false,"hidden":false,"merged":[]}
[]
[]
[]
[null,"Introduction"]
[null,"The commitment to incorporating impact into investment decision-making is core to impact investing. As the industry continues to grow, the need for aggregate, comparable impact performance data becomes increasingly paramount. Thus, the GIIN Healthcare Impact Performance Benchmark seeks to allow investors to understand and, importantly, compare their impact performance. This pioneering benchmark will focus on impact investments made in healthcare."," "]
[]
[null,"This effort uses metrics from the IRIS Catalog and aligns to the IRIS+ system of Core Metric Sets "]
[null,"as well as to the Impact Management Project's Dimensions of Impact and other standardized frameworks in the industry.",null," "]
[]
[]
[null,"Instructions"]
[]
[null,"Please enable macros so that this workbook will have full functionality."]
[null,"Enabling macros from external sources has become more difficult in more recent versions of Excel. We have included instructions in the original email on how to do so, but you can also reference the Microsoft Support page here and select 'Disable all macros with notification' and click enable for the macros on this sheet. You can also temporarily enable all macros while editing this sheet.\n\nIf you cannot enable macros (which allow you to multiselect), please reach out to jtate@thegiin.org."]
[]
[null,"Please avoid adding additional columns to this workbook. If you do, recognize that this will cause the multi-select columns to lose functionality."]
[]
[null,"Please complete the worksheet called Your Impact Results and provide annualized performance data on as many of your healthcare investments as you can. We also invite you to include impact data across multiple years for the same investment; in these cases, please fill in the investor and investment background information once and add impact data for each additional year in a new row. The Definitions worksheet defines key terms used throughout this spreadsheet."]
[]
[null,"We understand that some fields will not be relevant for you and therefore ask you to view each question as optional. Please fill out as much of the information as possible in the white cells, skipping the grey cells. For more information on data anonymity, confidentiality and data use, please see the “Confidentiality and Data Use” tab. Once you’ve completed the questionnaire, we will ask you to opt into submitting your data based on these terms. This effort forms part of a wider effort to enable investors to compare investments on the basis of impact results. We are very excited that you are collaborating with us to integrate impact into decision-making! We are convinced that this benchmarking effort will enhance your own investment decision-making.   "]
[null," "]

{"sheet":"Your Impact Results","index":2,"n_rows":309,"n_cols":65,"rows_kept":309,"cut":false,"hidden":false,"merged":[[7,15,8,15],[3,63,5,64],[5,10,5,12],[7,56,8,56],[7,64,8,64],[7,54,8,54],[7,61,8,61],[7,40,8,40],[7,43,8,43],[7,50,8,50],[7,58,8,58],[7,60,8,60],[7,46,8,46],[7,57,8,57],[7,59,8,59],[7,0,7,2],[5,5,5,6],[7,3,8,3],[7,9,8,9],[7,7,8,7]]}
["GIIN Healthcare Benchmark"]
["Direct Investments"]
[]
[null,"Investee & reporting year",null,"Fund context",null,null,null,"Investment context",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"KEY PERFORMANCE INDICATORS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Wrap-up"]
[null,null,null,"Please fill out just once per fund/vehicle.",null,null,null,"Please answer all following questions with respect to each investment.",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"KPI 1: Patients receiving treatment",null,null,null,null,"KPI 2: Increasing access of medical products and services for patients",null,null,"KPI 3: Patient savings",null,null,"KPI 4: Patient satisfaction",null,null,"KPI 5: Employees provided with healthcare training",null,null,null,"KPI 6: Decent jobs directly supported",null,null,null,"KPI 7: Investee revenue growth"]
[null,null,null,null,null,"DEI Lenses",null,"Organization","Investment features",null,"Enterprise value of investee, as of reporting year",null,null,null,null,null,"Investor contribution",null,null,"Investment objectives",null,null,"Investee features",null,null,null,null,null,null,null,null,null,null,null,null,"DEI Lenses",null,"KPI reporting & data confidence",null,"Metrics","KPI reporting & data confidence",null,"Metrics","KPI reporting & data confidence",null,"Metrics","KPI reporting & data confidence",null,"Metrics",null,"KPI reporting & data confidence",null,"Metrics","DEI Lenses","KPI reporting & data confidence",null,"Metrics","DEI Lenses",null,null,null,"KPI reporting & data confidence"]
["Number","Investee name","Year for which impact performance is reported","Fund/vehicle name","Fund assets under management (USD)","Percentage of investment committee that are women and/or gender non-binary","Percentage of investment committee that belong to populations historically marginalized on the basis of race or ethnicity","Investee website ","Year in which investment was made","Value of investment amount outstanding (USD), as of reporting year","Value of equity (USD) of investee","Value of liabilities (USD) of investee","Value of cash or equivalents (USD) of investee","Ratio of investment amount outstanding to enterprise value","Asset class of investment","Please describe 'other' asset class","Mechanisms used to engage investee","Mechanisms used to engage end stakeholders","Mechanisms used to embed impact goals into investment terms","Healthcare strategic goals of investment","SDGs aligned to investment","Target financial returns for investment","Stage of business at time of investment","Countries in which the investee currently operates","Primary country of operations","Geographic focus","Healthcare product/service type","Setting where patients receive care","Stage of the value chain","Quality assurance mechanisms","Certifications and/or frameworks","Please describe 'other' certifications and/or frameworks","Target stakeholder demographic","Disease/condition addressed","Number of patients receiving treatment","Number of patients identifying as women and/or gender non-binary individuals [GENDER LENS]","Number of patients from populations historically marginalized on the basis of race or ethnicity [RACIAL / ETHNIC EQUITY LENS]","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Number of patients provided new access to medical products/services","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Average patients savings premium experienced by the client (percentage written in decimal form)","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Net promoter score (percentage written in decimal form)","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Percentage of employees receiving training (excluding operational staff)","Training type","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Number of permanent, full-time decent jobs at or above a living wage at investee organization during reporting year","Number of permanent, full-time decent jobs at or above a living wage that are held by women and/or gender non-binary individuals [GENDER LENS]","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Investee revenue growth since the previous reporting year (percentage written in decimal form)","Percentage of founders who are women and/or gender non-binary individuals [GENDER LENS]","Percentage of investee owned by women and/or gender non-binary individuals [GENDER LENS]","Percentage of founders who are from groups historically marginalized due to race and/or ethnicity [RACIAL / ETHNIC EQUITY LENS]","Percentage of investee owned by groups historically marginalized due to race and/or ethnicity [RACIAL / ETHNIC EQUITY LENS]","If you cannot report on this KPI, select the reason below","Level of confidence in the data for this KPI","Do you agree to participate in this benchmark under the terms set out in the ‘Confidentiality and data use’ tab?","May we have your permission to disclose your organization's name as a participant in this impact performance benchmark?"]
["Instructions & Notes\nPlease fill in a new row for each unique investment; please also add multiple years of impact data for the same investment. Please skip greyed cells.",null,null,"Please fill in this column just once for each fund/vehicle.",null,"IRIS+: OI8709","IRIS+: OI8147 ","If applicable, please provide link below.",null,"For a debt investment, please share the difference between the original loan amount and the principal that has been repaid.\n\nFor an equity investment, please share the estimated valuation of your stake in the investee at the end of the reporting year.",null,null,null,"Calculation: Column J / (Column K + L + M)",null,"If cell is yellow, please provide a description of 'Other' asset class.",null,"IRIS+: OI7914",null,"Aligns to IRIS+ Strategic Goals in Access to Quality Healthcare",null,null,"Please see \"Definitions\" tab for guidance on business stages.","Please select all that apply by selecting one option at a time from the dropdown list.","Please select the country in which the majority or plurality of end-stakeholders reside.",null,"Please input the best description of the type of product/service provided by the investee. ",null,null,null,"Please enter Column AD (Quality assurance mechanisms) first to populate this column with answer options. ",null,"Please select all that apply. ","Please select all that apply. ","Please see \"Definitions\" tab for guidance on what constitutes receiving treatment.",null,null,"Please answer here if quantitative information for this KPI is not available.",null,"Please see \"Definitions\" tab for guidance on what constitutes new access.","Please answer here if quantitative information is not available.",null,"Please answer with the percent of price savings the client obtains by purchasing a product/service from the investee compared to the market price. See IRIS+ link below for calculation guidance.","Please answer here if quantitative information is not available.",null,"Please use net promoter score and not another measure of satisfaction.","Please answer here if quantitative information is not available.",null,null,"Please select all that apply.","Please answer here if quantitative information is not available.",null,"IRIS+: OD0660 - see definitions tab for guidance ","IRIS+: OI2444","Please answer here if quantitative information is not available.",null,"IRIS+: FP4761","IRIS+: OI0933","IIRS+: OI2840","IRIS+: OI0933","IRIS+: OI7194","Please answer here if quantitative information is not available.",null,null,"We will not share your investee name, just your investor organization name. All responses will be kept entirely confidential and findings will be reported only annonymized and in aggregate."]
[null,"IRIS+: OD5828","IRIS+: OD6951, IRIS+: OD7111",null,null,"IRIS+: OI7829","IRIS+: OI7829",null,null,null,null,null,null,"Please do not manually enter values into this column.",null,null,"Please select all that apply.","Please select all that apply. See 'Definitions' tab for guidance on end stakeholders.","Please select all that apply.","Please select all that apply.","Please select all that apply.",null,null," IRIS+: PD6424",null,"IRIS+: PD6384","Please see \"Definitions\" tab for additional guidance.","Please see \"Definitions\"  tab for additional guidance.","Please see \"Definitions\"  tab for additional guidance.","Please select all that apply.","Please select all that apply.",null,"IRIS+:PD5752","This aligns to WHO's ICD-11 classification. Click here to see more.","IRIS+: PI9327","IRIS+: PI8330","IRIS+: PI4237",null,null,"IRIS+: PI2822",null,null,"IRIS+: PI1748",null,null,"IRIS+: PI7163",null,null,"IRIS+: OI4229","IRIS+: OI5044",null,null,"IRIS+: PI4874","IRIS+: OI4724"]
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54]
[55]
[56]
[57]
[58]
[59]
[60]
[61]
[62]
[63]
[64]
[65]
[66]
[67]
[68]
[69]
[70]
[71]
[72]
[73]
[74]
[75]
[76]
[77]
[78]
[79]
[80]
[81]
[82]
[83]
[84]
[85]
[86]
[87]
[88]
[89]
[90]
[91]
[92]
[93]
[94]
[95]
[96]
[97]
[98]
[99]
[100]
[101]
[102]
[103]
[104]
[105]
[106]
[107]
[108]
[109]
[110]
[111]
[112]
[113]
[114]
[115]
[116]
[117]
[118]
[119]
[120]
[121]
[122]
[123]
[124]
[125]
[126]
[127]
[128]
[129]
[130]
[131]
[132]
[133]
[134]
[135]
[136]
[137]
[138]
[139]
[140]
[141]
[142]
[143]
[144]
[145]
[146]
[147]
[148]
[149]
[150]
[151]
[152]
[153]
[154]
[155]
[156]
[157]
[158]
[159]
[160]
[161]
[162]
[163]
[164]
[165]
[166]
[167]
[168]
[169]
[170]
[171]
[172]
[173]
[174]
[175]
[176]
[177]
[178]
[179]
[180]
[181]
[182]
[183]
[184]
[185]
[186]
[187]
[188]
[189]
[190]
[191]
[192]
[193]
[194]
[195]
[196]
[197]
[198]
[199]
[200]
[201]
[202]
[203]
[204]
[205]
[206]
[207]
[208]
[209]
[210]
[211]
[212]
[213]
[214]
[215]
[216]
[217]
[218]
[219]
[220]
[221]
[222]
[223]
[224]
[225]
[226]
[227]
[228]
[229]
[230]
[231]
[232]
[233]
[234]
[235]
[236]
[237]
[238]
[239]
[240]
[241]
[242]
[243]
[244]
[245]
[246]
[247]
[248]
[249]
[250]
[251]
[252]
[253]
[254]
[255]
[256]
[257]
[258]
[259]
[260]
[261]
[262]
[263]
[264]
[265]
[266]
[267]
[268]
[269]
[270]
[271]
[272]
[273]
[274]
[275]
[276]
[277]
[278]
[279]
[280]
[281]
[282]
[283]
[284]
[285]
[286]
[287]
[288]
[289]
[290]
[291]
[292]
[293]
[294]
[295]
[296]
[297]
[298]
[299]
[300]

{"sheet":"Definitions","index":3,"n_rows":51,"n_cols":2,"rows_kept":51,"cut":false,"hidden":false,"merged":[]}
["Investees and stakeholders"]
["Investee: The recipient of investment capital, typically a company, project, or real asset."]
["Stakeholder: Sometimes referred to as 'beneficiary'; the person(s) or enterprise(es) that derive advantages from an investment, such as clients, employees, businesses, etc."]
[]
["Stages of business"]
["Seed/start-up: Business idea exists, but little has been established operationally; pre-revenues."]
["Venture: Operations are established, and the company may or may not be generating revenues, but does not yet have positive EBITDA."]
["Growth: Company has positive EBITDA and is growing."]
["Mature: Company has stabilized at scale and is operating profitably."]
[]
["Healthcare service type"]
["Preventative: Routine care that includes screenings, check-ups and patient counseling to prevent illnesses, disease or other health problems."]
["Diagnostic: The act or process of identifying or determining the nature and cause of a disease or injury through evaluation of patient history, examination of a patient and review of laboratory data."]
["Treatment: The direct medical or dental care for previously-diagnosed disease, including taking drugs, medication, insulin, or similar substances."]
["Palliative: Care that provides symptom relief, comfort and support to individuals living with serious illnesses. Palliative care refers to relieving the symptoms of an incurable medical condition."]
[]
["Setting"]
["Hospital: Care received in an establishment that is permanently staffed by at least one physician, can offer inpatient accommodation and can provide active medical and nursing care."]
["Specialized care facility: Care received in a facility other than a hospital providing specialized treatment. Examples include facilities focused on dentistry, eye care, maternal care and other relevant specialties as removed from a generalized hospital setting."]
["Community: Care received in non-medical public facilities such as schools, fairs, libraries and community centers."]
["Home-based: Care received in the private home of the patient or their family."]
["Virtual: Care recieved over the phone or internet (also known as telehealth, telemedicine, or eHealth)."]
[]
["Stages of value chain"]
["Production: The process of making or manufacturing goods and products from raw materials or components. Production takes inputs and uses them to create an output which is fit for consumption – a good or product which has value to an end-user or customer."]
["Procurement and distribution: Procurement is the process of purchasing goods or services, usually in reference to business spending. Distribution is the process of moving goods or services through a network of businesses or intermediaries until it reaches the end consumer."]
["Product and service provision: Healthcare service provision refers to direct health treatment and related services and/or products, as applied directly to patient care or end-user use."]
["Disposal: The process or products used to safely destroy, re-use and/or remove waste."]
[]
["Key performance indicators"]
["Receiving treatment: “Treatment” means the provision, coordination or management of health care and related services among health care providers or by a health care provider with a third party. It also includes consultation between health care providers regarding a patient or the referral of a patient from one health care provider to another."]
["Patients receiving new access: Individuals who previously were not served by the healthcare product or service because of the distance they had to travel, the cost they had to pay or requirements of entry that prohibited them from seeking such services."]
[]
[]
["Miscellaneous"]
["Living wage: Remuneration received for a standard work week by a worker in a particular time and place sufficient to afford a decent standard of living, including food, water, housing, education, healthcare, transport, clothing, and other essential needs, including provision for unexpected events"]
[]
["Decent jobs"]
["Decent jobs are those at organizations with each of the following policies in place."]
[]
["Policy","IRIS+ Code"]
["Fair Hiring/Recruiting Practices","OI1150"]
["Fair Career Advancement Practices ","OI4884"]
["Fair Compensation Practices","OI3819"]
["Fair Dismissal Policy","OI9478"]
["Sexual Harassment Policy","OI9088"]
["Worker Safety","OI8001"]
["Employee Feedback","OI3601"]
["Child Labor Policy","OI4432"]
["Community Service","OI4324"]
["Occupational Injuries","OI3757"]

{"sheet":"Confidentiality and data use","index":4,"n_rows":7,"n_cols":2,"rows_kept":7,"cut":false,"hidden":false,"merged":[]}
[]
[null,"CONFIDENTIALITY UNDERTAKING AND DATA USE BY THE GIIN"]
[null,"TERMS OF CONTRIBUTION"]
[null,"Thank you for participating in our research. The purpose of our research is to collect data on impact investing and impact investment to advance knowledge of impact investing. As we describe in detail below, we will hold your data in strict confidence, stored in a secure, password-protected electronic format that can only be accessed by researchers authorized by the Global Impact Investing Network, Inc. (“GIIN”). By completing this instrument and sharing data with us, you are indicating your understanding of, and consent to, the confidentiality and data-use terms described below.   "]
[]
[null,"CONFIDENTIALITY UNDERTAKING AND USE OF YOUR DATA"]
[null,"Thank you for agreeing to voluntarily contribute to the data repository owned, maintained and managed by the GIIN.   \n \nBy selecting the \"yes\" option in the 'Your Impact Results' tab, you indicate your acceptance of and agreement with this Confidentiality Undertaking and Data Use Policy (the “Undertaking”) and you expressly acknowledge that, if you are agreeing to these terms and this Undertaking on behalf of an entity, you are authorized to do so on behalf of that entity. Please click here to see the full terms of the Undertaking.  "]